Skip to content
TrustList
Brightstone Venture Capital cover

About Brightstone Venture Capital

Recently raised $80M in a Series D Funding

Cellular diagnostic testing Enabling more personalized medicine for targeted therapy selection and drug discovery markets

BiteSquad enables on-demand delivery of restaurant food and other products via its online ordering and logistics platform

$321 million sale to WAITR Holdings (NASDAQ WTRH) StemoniX is setting a new standard for stem cell technologies to make micro-organs biological relevant, and providing their IPS-based platforms to pharmaceutical and research institutions to test for drug toxicity and efficacy

One simple storage solution that is faster than Amazon S3 yet cheaper than Amazon Glacier

Recently raised $112M in a Series C Funding CNEX is founded semiconductor industry veterans and delivers SSD controllers with high-performance and low latency, that provide flexibility with host-based FTL, and Ethernet I/O for scalability

Recently raised $10M in a Series G Funding

Gravie is a next-generation health insurance platform focused on helping consumers achieve insurance independence by enabling them to choose and buy insurance, pay for it, and manage all their health care expenses in one place

Recently raised $75M in a Series E Funding

The Miromatrix Medical technology has the potential to enable the creation of fully biological replacement organs for the human body

HomeSpotter is a beautiful mobile real estate search application with built-in chat that makes collaboration, fast, easy, and fun

$40 million sale to LoneWolf Technologies (Private) FlipGrid is a social education technology platform, utilizing asynchronous video to create a rich classroom discussion environment and amplify student voice

$91 million sale to Microsoft (NASDAQ MSFT) Vathys builds deep learning processors Its architecture is a clean rethink of the processor, unconstrained by legacy limitations Vathys was born and bred for deep learning

CodeStream is a free service that lets developers create annotated comments on their code and chat within their IDE, then preserves those discussions linked to the code they refer to

$40 million sale to New Relic (NASDAQ NEWR) The rise of multidrug resistant superbacteria and cancer has rendered many treatment options useless Viosera predicts and blocks resistance evolution https://www viosera com/ Intact Therapeutics is a next generation localized drug delivery technology platform http://intacttherapeutics com/ Aria CV is developing a pulmonary assist device to improve the lives of patients living with Pulmonary Arterial Hypertension

Eternal is a avatar based social network giving groups of users a canvas for their friendships to live on and grow

Cryosa is developing novel treatments for patients with sleep disordered breathing

Recently raised $21 5M in a Series B Funding

Afriex is a blockchain based mobile remittance platform

Recently raised $10M in a Series A Funding Xplore provides a robust mission platform to some of the most challenging destinations throughout the solar system, not just low earth orbit

Recently raised $25M in a Series Seed Funding

Categories & features

Ask TrustList to introduce you to Brightstone Venture Capital

TrustList reads every request before passing it on, and sends it only where the funder's stage and focus look like a fit. We do not charge for introductions, and we cannot promise a reply.

Protected by reCAPTCHA — Google Privacy Policy and Terms apply.

Reviews

Write the first review of Brightstone Venture Capital

Used it? Your experience helps other buyers decide.

Write a review

Questions & answers

No questions yet. Be the first to ask about Brightstone Venture Capital.

Brightstone Venture Capital alternatives

Similar listings buyers compare against this one.